PPP1CA and prostate carcinoma: In cancer, amplification of the PPP1CA gene causes aberrant activation of mitogen‐activated protein kinase (MAPK) in prostate cancer,12 and in glioblastoma, nuclear PP1A expression is associated with survival of patients with p53 expressing tumours.13